Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer

ABSTRACT The conjunction of atrial fibrillation (AF) and venous thromboembolism (VTE) is common in clinical practice. Over the last 2 decades, a significant number of articles (2500) have been published about AF and VTE. To effectively analyze and present these vast amounts of information, this stud...

Full description

Bibliographic Details
Main Authors: Lina Miao, Junhe Shi, Haixu Yu, Lei Song, Chunlin Zhu, Dazhuo Shi, Jie Gao
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.029810
_version_ 1797689825887780864
author Lina Miao
Junhe Shi
Haixu Yu
Lei Song
Chunlin Zhu
Dazhuo Shi
Jie Gao
author_facet Lina Miao
Junhe Shi
Haixu Yu
Lei Song
Chunlin Zhu
Dazhuo Shi
Jie Gao
author_sort Lina Miao
collection DOAJ
description ABSTRACT The conjunction of atrial fibrillation (AF) and venous thromboembolism (VTE) is common in clinical practice. Over the last 2 decades, a significant number of articles (2500) have been published about AF and VTE. To effectively analyze and present these vast amounts of information, this study uses bibliometric research methods to categorize and consolidate these publications. The number of publications has increased yearly, especially since 2012. The United States was the most prolific country, with 1054 studies published. The most productive institution was McMaster University. Gregory Y.H. Lip was the most prolific author. The keyword analysis identified that the research focuses from 2003 to 2014 were factor Xa inhibitor, dabigatran etexilate, direct thrombin inhibitor, double‐blind, deep vein thrombosis, molecular weight heparin, stroke prevention, etc. From 2015 to 2016, research mainly focused on venous thromboembolism, antithrombotic therapy, anticoagulant, warfarin, atrial fibrillation, stroke, and pulmonary embolism. Studies during 2017 to 2022 focused on apixaban, direct oral anticoagulant, rivaroxaban, dabigatran, hemorrhage, edoxaban, medicine efficacy and safety, risk factors, clinical management, and vitamin K antagonists. Since 2018, novel oral anticoagulants have been the most commonly used keywords. On the whole, most studies of AF and VTE focus on pathogenesis and therapeutic drugs. The causal relationship between AF and VTE, the effectiveness and safety of novel oral anticoagulants in the treatments, the anticoagulant regimen of AF and VTE co‐disease, and the treatment regimen for vulnerable populations such as the elderly or obese people were the focus of current research and will continue to be the central point of future research.
first_indexed 2024-03-12T01:51:09Z
format Article
id doaj.art-4663decd2e224623988fc6091546a98e
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-03-12T01:51:09Z
publishDate 2023-09-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-4663decd2e224623988fc6091546a98e2023-09-08T12:39:35ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802023-09-01121710.1161/JAHA.123.029810Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewerLina Miao0Junhe Shi1Haixu Yu2Lei Song3Chunlin Zhu4Dazhuo Shi5Jie Gao6Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing ChinaXiyuan Hospital, China Academy of Chinese Medical Sciences Beijing ChinaBeijing Jishuitan Hospital Beijing ChinaXiyuan Hospital, China Academy of Chinese Medical Sciences Beijing ChinaXiyuan Hospital, China Academy of Chinese Medical Sciences Beijing ChinaXiyuan Hospital, China Academy of Chinese Medical Sciences Beijing ChinaXiyuan Hospital, China Academy of Chinese Medical Sciences Beijing ChinaABSTRACT The conjunction of atrial fibrillation (AF) and venous thromboembolism (VTE) is common in clinical practice. Over the last 2 decades, a significant number of articles (2500) have been published about AF and VTE. To effectively analyze and present these vast amounts of information, this study uses bibliometric research methods to categorize and consolidate these publications. The number of publications has increased yearly, especially since 2012. The United States was the most prolific country, with 1054 studies published. The most productive institution was McMaster University. Gregory Y.H. Lip was the most prolific author. The keyword analysis identified that the research focuses from 2003 to 2014 were factor Xa inhibitor, dabigatran etexilate, direct thrombin inhibitor, double‐blind, deep vein thrombosis, molecular weight heparin, stroke prevention, etc. From 2015 to 2016, research mainly focused on venous thromboembolism, antithrombotic therapy, anticoagulant, warfarin, atrial fibrillation, stroke, and pulmonary embolism. Studies during 2017 to 2022 focused on apixaban, direct oral anticoagulant, rivaroxaban, dabigatran, hemorrhage, edoxaban, medicine efficacy and safety, risk factors, clinical management, and vitamin K antagonists. Since 2018, novel oral anticoagulants have been the most commonly used keywords. On the whole, most studies of AF and VTE focus on pathogenesis and therapeutic drugs. The causal relationship between AF and VTE, the effectiveness and safety of novel oral anticoagulants in the treatments, the anticoagulant regimen of AF and VTE co‐disease, and the treatment regimen for vulnerable populations such as the elderly or obese people were the focus of current research and will continue to be the central point of future research.https://www.ahajournals.org/doi/10.1161/JAHA.123.029810atrial fibrillationbibliometricsCiteSpacevenous thromboembolismvisual analysis
spellingShingle Lina Miao
Junhe Shi
Haixu Yu
Lei Song
Chunlin Zhu
Dazhuo Shi
Jie Gao
Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
atrial fibrillation
bibliometrics
CiteSpace
venous thromboembolism
visual analysis
title Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
title_full Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
title_fullStr Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
title_full_unstemmed Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
title_short Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
title_sort studies on atrial fibrillation and venous thromboembolism in the past 20 years a bibliometric analysis via citespace and vosviewer
topic atrial fibrillation
bibliometrics
CiteSpace
venous thromboembolism
visual analysis
url https://www.ahajournals.org/doi/10.1161/JAHA.123.029810
work_keys_str_mv AT linamiao studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer
AT junheshi studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer
AT haixuyu studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer
AT leisong studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer
AT chunlinzhu studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer
AT dazhuoshi studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer
AT jiegao studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer